Table 4 Rate of concordance of recommendations according to different sections in the primary analysis and sensitivity analysis

Primary analysis

 Blood pressure measurement^a

1

1 (100)

1

1 (100)

 Diagnosis of hypertension^b

5

1 (20.0)

4

3 (75.0)

 Investigations of patients with hypertension^c

11

4 (36.3)

10

4 (40.0)

 Lifestyle modifications^d

6

6 (100)

6

6 (100)

 Goal blood pressure^e

8

0 (0)

7

0 (0)

 Pharmacotherapy for patients with hypertension and no comorbidity^f

10

6 (60.0)

10

6 (60.0)

 Pharmacotherapy for patients with hypertension and comorbidity^g

18

12 (66.7)

13

11 (84.6)

Sensitivity analysis excluding insufficient ratings

 Blood pressure measurement^a

1

1 (100)

1

1 (100)

 Diagnosis of hypertension^b

5

2 (40.0)

4

4 (100)

 Investigations of patients with hypertension^c

11

5 (45.4)

10

4 (40.0)

 Lifestyle modifications^d

6

6 (100)

6

6 (100)

 Goal blood pressure^e

8

0 (0)

7

0 (0)

 Pharmacotherapy for patients with hypertension and no comorbidity^f

10

6 (60.0)

10

6 (60.0)

 Pharmacotherapy for patients with hypertension and comorbidity^g

14

13 (92.9)

11

11 (100)